Lack of distinction between “z” drugs in insomnia
Treatment of insomnia should be driven by the cost of treatment because of a lack of compelling evidence to distinguish between zaleplon, zolpidem, zopiclone and shorter-acting benzodiazepines.
The recommendation to prescribe the drug with the lowest price comes
from the National Institute for Clinical Excellence, which published
recommendations on use
of the “z” drugs this week.
The guidance adds that non-pharmacological measures should be considered
before hypnotic drug therapy is used and, as with other hypnotics, that
the “z” drugs be prescribed for short periods only, in accordance
with their licences.
NICE also advises that switching between these hypnotics should only
occur if a patient experiences adverse effects considered to be directly
related to a specific agent. These are also the only circumstances in
which more expensive drugs are recommended, according to the guidance.
Patients who have not responded to one of these hypnotics should not
be prescribed any of the others, the institute says.
David Taylor, chief pharmacist at the South London and Maudsley NHS Trust,
commented to The Journal that there are
differences between the “z” drugs and benzodiazepines in
terms of pharmacology.
The “z” drugs have an abrupt onset and are shorter acting.
Despite previous advice to limit the use of hypnotics, Dr Taylor believes
they are still too readily prescribed and sleep hygiene methods are often
not explored fully before resorting to drugs.
The guidance comments that pharmacists can deliver advice and education
on non-pharmacological measures to manage insomnia. However, it adds
that access to many of these therapies, such as cognitive behavioural
therapy, is restricted through a combination of lack of trained therapists,
costs and a poor understanding of available options.
The guidance points out that up to 40 per cent of people with insomnia
self-medicate with non-prescription hypnotics, such as sedative antihistamines,
available from pharmacies without prescription.
NICE this week also issued guidelines on Caesarean section and on procedures
to treat heavy menstrual bleeding. |